Yes it is a bad thing but what do you expect after going from .02 to .0004???? Same with Bmsn..If you are expecting actual revenue here then you are in the wrong stock. Biotech companies are extremely expensive to keep up and when they dont even have a drug on the market making money then you are losing money. Both bmsn and entb losing money everyday but that is not why most people are here for. They are here for the potential of profits to be made.
Also on entb 10q it states they are looking for vet hospitals which is a huge revenue stream and they will be able to test there new vaccine there to that will bring them revenue also in the future.